Nephrocare Health Services Limited (NSE:NEPHROPLUS)
India · Delayed Price · Currency is INR 628.80
-6.90 (-1.09%)
At close: Jul 20, 2026
NSE:NEPHROPLUS Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 9,988 | 7,558 | 5,662 | 4,373 | 3,169 | |
Revenue Growth (YoY) | 32.16% | 33.50% | 29.47% | 37.99% | 11.40% |
Cost of Revenue | 6,194 | 4,886 | 3,830 | 3,231 | 1,879 |
Gross Profit | 3,794 | 2,673 | 1,832 | 1,142 | 1,290 |
Selling, General & Admin | 251.7 | 143.36 | 70.39 | 44.99 | 126.15 |
Other Operating Expenses | 1,259 | 837.84 | 713.65 | 591.8 | 913.86 |
Operating Expenses | 2,406 | 1,717 | 1,355 | 1,125 | 1,476 |
Operating Income | 1,388 | 956.04 | 476.58 | 17.16 | -186.26 |
Interest Expense | -579.66 | -188.67 | -190 | -145.86 | -96.93 |
Interest & Investment Income | 97.07 | 119.55 | 83.25 | 42.24 | 35.56 |
Earnings From Equity Investments | -30.93 | - | - | - | - |
Currency Exchange Gain (Loss) | 24.46 | -10.1 | -28.2 | 10.59 | - |
Other Non Operating Income (Expenses) | 9.49 | -5.74 | -9.37 | -10.04 | -5.44 |
EBT Excluding Unusual Items | 908.86 | 871.08 | 332.26 | -85.91 | -253.06 |
Gain (Loss) on Sale of Investments | 91.35 | 7.55 | - | - | - |
Gain (Loss) on Sale of Assets | -12.76 | - | -0.65 | - | - |
Asset Writedown | -12.71 | -4.26 | - | - | -27.68 |
Pretax Income | 974.74 | 874.37 | 331.61 | -85.91 | -280.74 |
Income Tax Expense | 206.34 | 203.41 | -19.72 | 31.98 | -60.99 |
Net Income | 768.4 | 670.96 | 351.33 | -117.89 | -219.75 |
Net Income to Common | 768.4 | 670.96 | 351.33 | -117.89 | -219.75 |
Net Income Growth | 14.52% | 90.98% | - | - | - |
Shares Outstanding (Basic) | 91 | 81 | 77 | 77 | 8 |
Shares Outstanding (Diluted) | 95 | 84 | 80 | 77 | 8 |
Shares Change (YoY) | 13.22% | 4.81% | 3.72% | 829.32% | -64.32% |
EPS (Basic) | 8.48 | 8.28 | 4.55 | -1.53 | -26.51 |
EPS (Diluted) | 8.10 | 8.01 | 4.40 | -1.53 | -26.51 |
EPS Growth | 1.12% | 82.05% | - | - | - |
Free Cash Flow | 1,136 | 355.72 | -50.69 | -603 | -310.52 |
Free Cash Flow Per Share | 11.98 | 4.25 | -0.63 | -7.83 | -37.45 |
Gross Margin | 37.98% | 35.36% | 32.36% | 26.12% | 40.70% |
Operating Margin | 13.90% | 12.65% | 8.42% | 0.39% | -5.88% |
Profit Margin | 7.69% | 8.88% | 6.21% | -2.70% | -6.93% |
Free Cash Flow Margin | 11.38% | 4.71% | -0.90% | -13.79% | -9.80% |
EBITDA | 2,140 | 1,565 | 945.4 | 419.36 | 170.71 |
EBITDA Margin | 21.43% | 20.70% | 16.70% | 9.59% | 5.39% |
D&A For EBITDA | 752.05 | 608.7 | 468.82 | 402.2 | 356.97 |
EBIT | 1,388 | 956.04 | 476.58 | 17.16 | -186.26 |
EBIT Margin | 13.90% | 12.65% | 8.42% | 0.39% | -5.88% |
Effective Tax Rate | 21.17% | 23.26% | - | - | - |
Revenue as Reported | 10,234 | 7,699 | 5,747 | 4,433 | 3,205 |
Advertising Expenses | 115.68 | 52.97 | 18.75 | 12.78 | 88.5 |